Position in IMCR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,270,339
+$1,019,804 QoQ
Shares Held
42,134
+483.7% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 76.96159870888118.ToString("F0")%
Shared 0.ToString("F0")%
None 23.038401291118813.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Derivatives in IMCR
reported options exposure · as of Jun 30, 2023CallValue
$1,798,800
CallShares
30,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. IMCR ranks #237 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in IMCR
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,270,339 | 42,134 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $250,535 | 7,218 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,498,029 | 41,234 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $707,680 | 22,552 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,225,835 | 176,132 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,150,827 | 140,706 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,360,972 | 43,719 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $447,313 | 13,199 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $863,200 | 13,280 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $89,430 | 1,309 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $76,707 | 1,478 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,798,800 | 30,000 | Call | Defined | 2023-08-11 | |
| 2023-06-30 | $112,483 | 1,876 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,450,912 | 69,800 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $207,648 | 4,200 | Put | Defined | 2023-05-12 | |
| 2023-03-31 | $81,821 | 1,655 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $736,203 | 12,900 | Call | Defined | 2023-02-08 | |
| 2022-12-31 | $239,694 | 4,200 | Put | Defined | 2023-02-08 | |
| 2022-12-31 | $373,750 | 6,549 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $277,978 | 5,922 | Shares | Defined | 2022-11-10 | |
| 2022-09-30 | $197,148 | 4,200 | Put | Defined | 2022-11-10 | |
| 2022-06-30 | $264,751 | 7,096 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $251,399 | 8,408 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $323,395 | 9,445 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $519,017 | 14,001 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $469,146 | 12,014 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $496,919 | 11,673 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||